This study was made available online in May 2022
The authors of “68Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment” include Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, and Andrei Iagaru, Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, California; Benjamin I. Chung, Alan E. C. Thong, and Geoffrey Sonn, Department of Urology, Stanford University, Stanford, California; and Andreas M. Loening and Pejman Ghanouni, Department of Radiology, Division of Body MRI, Stanford University, Stanford, California.
Ad Statistics
Times Displayed: 109546
Times Visited: 6640 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Back to HCB News
